Skip to content

VRTXVERTEX PHARMACEUTICALS INC

CUSIP 92532F100 · common stock

5 tracked investors held VERTEX PHARMACEUTICALS INC (VRTX) at the end of Q3 2026, worth $50.1M in total. The largest holder was Joel Greenblatt, with 0.0% of its portfolio. Mario Gabelli opened a new position this quarter.

Holders · Q3 2026
5
New holders
1
Value held
$50.1M
Quarter-end price (est.)
$522.81

Investors holding VRTX · Q3 2026

InvestorWeightSharesValueChange
Joel Greenblatt
Gotham Asset Management, LLC
0.03%33,266$17.4MADD+75.2%
Ken Fisher
Fisher Asset Management, LLC
0.00%28,676$15MADD+17.2%
Tweedy Browne
Tweedy, Browne Co LLC
1.11%26,013$13.6MREDUCE-35.2%
Ron Baron
BAMCO Inc. (Baron Capital)
0.01%7,400$3.9MADD+23.3%
Mario Gabelli
GAMCO Investors, Inc.
0.00%400$209.1KNEW

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Torray Funds1.02%15,215$7.6MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026511$50.1M$522.81
Q2 2026501$52.1M$496.73
Q1 2026601$58.2M$446.54
Q4 2025700$66.4M$453.36